BioMarker Pharmaceuticals Inc.

Private Company, Headquarters Location
5941 Optical Ct., San Jose, CA 95138-1400, United States
(408)257-2000, (408)356-6661 fax, http://www.biomarkerinc.com

Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Drug development focusing on mechanisms underlying aging and age-related diseases.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

BioMarker Pharmaceuticals Inc., News and Information

NuGEN Enters the Next Generation Sequencing Arena With the Ovation[R] RNA-Seq System.
Genomics & Genetics Weekly; 12/18/2009; 1029 words; ...NuGEN Technologies, Inc., a pace-setter...NuGEN Technologies, Inc). Ovation is the...for larger-scale biomarker discovery projects...Genomics, Health, Pharmaceutical, RNA Research, NuGEN Technologies Inc. This article was...

CRi Announces Results of Signaling Pathway Protein Study.(Clinical report)
Blood Weekly; 12/17/2009; 1376 words; ...Research & Instrumentation, Inc. (CRi), a leader...technologies in clinical biomarker analysis for developing...http://www.cri-inc.com/files/CRi...Learn more at www.cri-inc.com. About Cell Signaling...Oncology, Other Health, Pharmaceutical, Pharmaceut

Reports from University catholique of Louvain add new data to research in chronic lymphocytic leukemia therapy.(Report)
Blood Weekly; 12/17/2009; 1321 words; ...frequently altered. We identified a novel biomarker of chemosensitivity based on the induction...Haematology is: Blackwell Publishing Inc., 350 Main St., Malden, MA 02148...Neurology, Nucleoside Analog, Oncology, Pharmaceuticals, Therapy, Treatment. This article...

Clarient Granted Exclusive License to Commercialize Cancer Biomarker by Minerva Biotechnologies.
Cancer Weekly; 12/15/2009; 1205 words; Clarient, Inc. (NASDAQ:CLRT...oncologists and the pharmaceutical industry, announced...MUC1* protein, a biomarker researchers believe...see also Clarient, Inc.; Minerva Biotechnologies...Oncology, Pathology, Pharmaceuticals, Solid Cancers, Solid...s Health, Clarient Inc.; Minerva ...

Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman.
Cancer Weekly; 12/8/2009; 978 words; ...Discovery, Inc., which...appointment of pharmaceutical industry...Synaptic Pharmaceuticals and Archemix...development of biomarker and pharmacogenomic...Synaptic Pharmaceuticals and Archemix, Inc) and experience...with large pharmaceutical companies...Oncology, ...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.